An open-label, randomized cross-over bioavailability study of oral paclitaxel and HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours
Year: 2017
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Authors: C G C A Jackson, S. Deva, K. Bayston, P. Barlow, K. Eden, N. Hung, G. Fetterly, D. Cutler, R. Kwan, D. Kramer, W-K Chan, T. Hung
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2769477248
